People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Biotechnology, Other, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Finch Therapeutics Group, Inc. | — | Biotechnology | Series C | $179.9M | $3.5B | 2018 |
| Thunder Biotech, Inc. | — | Biotechnology | Series A | $24.5M | $634K | 2024 |
| Finch Therapeutics, Inc. | — | Biotechnology | Seed | $4.5M | $165.8M | 2015 |
| Screamin Media Group, Inc. | — | Other | Pre-Seed | $1.2M | $4.1M | 2010 |
| Flexilis Inc | — | Other Technology | Pre-Seed | $1.0M | $42.4M | 2009 |
James Burgess at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James Burgess on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mark Smith | 2 | 28 |
| Andrew Noh | 2 | 2 |
| Zain Kassam | 2 | 2 |
| DAVID WEIDEN | 1 | 13 |
| Kevin Hartz | 1 | 5 |
| John Hering | 1 | 4 |
| Scott Peterson | 1 | 4 |
| JEFFREY NELSON | 1 | 3 |
| D. Brent Israelsen | 1 | 2 |
| Katie Thompson | 1 | 2 |
| Steven Tanner | 1 | 2 |
| Chris Lange | 1 | 2 |
| Jeff Hone | 1 | 1 |
| Barry Mower | 1 | 1 |
| Kim O'Neill | 1 | 1 |
| Kent Misener | 1 | 1 |
| William Perkins | 1 | 1 |
| Robert P.K. Mooney | 1 | 1 |
| Kim L. O'Neill | 1 | 1 |
| Steven A. Tanner | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.